glp-1 tx How medications are transforming diabetes and weight loss treatment How GLP-1 drugs are changing

Summary: GLP-1 agonists can be used in transplant patients to manage post-transplant diabetes and weight gain, with minimal pharmacokinetic interactions with immunosuppressants, though careful monitoring of immunosuppressant levels and gastrointestinal tolerance is essential

These events often revolve around food and drink, and managing reduced appetite, potential nausea, or simply feeling under the weather could detract from your enjoyment and the significance of the occasion

Another important difference lies in the interpretation of risk and benefit

PMID 21950636

Eli Lilly is now armed on the GLP-1 front in both diabetes and weight loss as its finally received US Food and Drug Administration (FDA) approval for Zepbound (tirzepatide), the obesity version of diabetes sensation Mounjaro (tirzepatide)